Clinical presentation and treatment of orthopaedic implant-associated infection

Journal of Internal Medicine

Volumn 276, Issue 2, 2014, Pages 111-119

  Zimmerli, W ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Biofilm; Fluoroquinolone; Internal fixation; Prosthetic joint infection; Rifampicin; Staphylococcus aureus

Indexed keywords

ANTIINFECTIVE AGENT; POLYPEPTIDE ANTIBIOTIC AGENT; RIFAMPICIN;

ANTIBIOTIC THERAPY; BIOFILM; CHRONIC OSTEOMYELITIS; CLINICAL FEATURE; DEBRIDEMENT; FRACTURE HEALING; HUMAN; INTERNAL FIXATOR; MICROORGANISM; NONHUMAN; ORTHOPEDIC IMPLANT; PERIPROSTHETIC JOINT INFECTION; PRIORITY JOURNAL; PROSTHESIS INFECTION; QUORUM SENSING; REVIEW; STAPHYLOCOCCUS;

BIOFILM; FLUOROQUINOLONE; INTERNAL FIXATION; PROSTHETIC JOINT INFECTION; RIFAMPICIN; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; COATED MATERIALS, BIOCOMPATIBLE; DEBRIDEMENT; FRACTURES, BONE; HUMANS; INTERNAL FIXATORS; MALE; MIDDLE AGED; OSTEOMYELITIS; PROSTHESIS-RELATED INFECTIONS; REOPERATION; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 84904260390     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12233     Document Type: Review

References (86)

1. Muller ME. Internal fixation for fresh fractures and for non-union. Proc R Soc Med 1963; 56: 455-60.
2. Harris WH, Sledge CB. Total hip and total knee replacement. N Engl J Med 1990; 323: 725-31.
3. Kurtz SM, Lau E, Schmier J et al. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 2008; 23: 984-91.
4. Jamsen E, Virta LJ, Hakala M et al. The decline in joint replacement surgery in rheumatoid arthritis is associated with a concomitant increase in the intensity of anti-rheumatic therapy: a nationwide register-based study from 1995 through 2010. Acta Orthop 2013; 84: 331-7.
5. Del Pozo JL, Patel R. Clinical practice. Infection associated with prosthetic joints. N Engl J Med 2009; 361: 787-94.
6. Zimmerli W, Moser C. Pathogenesis and treatment concepts of orthopaedic biofilm infections. FEMS Immunol Med Microbiol 2011; 65: 158-68.
7. Zimmerli W, Waldvogel FA, Vaudaux P et al. Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis 1982; 146: 487-97.
8. Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J Clin Invest 1984; 73: 1191-200.
9. Zimmerli W, Sendi P. Pathogenesis of implant-associated infection: the role of the host. Semin Immunopathol 2011; 33: 295-306.
10. Zimmerli W. Antibiotic prophylaxis. In: Rüedi T et al., eds. AO Principles of Fracture Management. New York: Thieme, 2007; 425-33.
11. Gustilo RB, Merkow RL, Templeman D. The management of open fractures. J Bone Joint Surg Am 1990; 72: 299-304.
12. Laffer RR, Graber P, Ochsner PE et al. Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect 2006; 12: 433-9.
13. Kessler B, Sendi P, Graber P et al. Risk factors for periprosthetic ankle joint infection: a case-control study. J Bone Joint Surg Am 2012; 94: 1871-6.
14. Murdoch DR, Roberts SA, Fowler Jr VG Jr et al. Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clin Infect Dis 2001; 32: 647-9.
15. Sendi P, Banderet F, Graber P et al. Periprosthetic joint infection following Staphylococcus aureus bacteremia. J Infect 2011; 63: 17-22.
16. Zimmerli W, Sendi P. Antibiotics for prevention of periprosthetic joint infection following dentistry: time to focus on data. Clin Infect Dis 2010; 50: 17-9.
17. Steckelberg JM, Osmon DR. Prosthetic joint infection. In: Waldvogel FA, Bisno AL, eds. Infections Associated with Indwelling Medical Devices. Washington, DC: ASM Press, 2000; 173-209.
18. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004; 351: 1645-54.
19. Osmon DR, Berbari EF, Berendt AR et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013; 56: e1-25.
20. Law MD Jr, Stein RE. Late infection in healed fractures after open reduction and internal fixation. Orthop Rev 1993; 22: 545-52.
21. Ochsner PE, Sirkin MS, Trampuz A. Acute Infections. In: Rüedi TP, Buckely RE, Moran CG, eds. AO Principles of Fracture Management (vol 1). Stuttgart and New York: Thieme, 2007; 520-40.
22. Horan TC, Gaynes RP, Martone WJ et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control 1992; 20: 271-4.
23. Berbari EF, Hanssen AD, Duffy MC et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 1998; 27: 1247-54.
24. Schinsky MF, Della Valle CJ, Sporer SM et al. Perioperative testing for joint infection in patients undergoing revision total hip arthroplasty. J Bone Joint Surg Am 2008; 90: 1869-75.
25. Bedair H, Ting N, Jacovides C et al. The Mark Coventry Award: diagnosis of early postoperative TKA infection using synovial fluid analysis. Clin Orthop Relat Res 2013; 469: 34-40.
26. Trampuz A, Hanssen AD, Osmon DR et al. Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med 2004; 117: 556-62.
27. Zimmerli W, Sendi P. Orthopaedic implant associated infections. In: Bennett JE, Dolin R, Blaser MJ, eds. Principles and Practice of Infectious Diseases. Philadelphia: Elsevier, 2014 (in press).
28. Zimmerli W, Widmer AF, Blatter M et al. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998; 279: 1537-41.
29. Gehrke T, Zahar A, Kendoff D. One-stage exchange: it all began here. Bone Joint J 2013; 95-B(11 Suppl A): 77-83.
30. Maderazo EG, Judson S, Pasternak H. Late infections of total joint prostheses. A review and recommendations for prevention. Clin Orthop Relat Res 1988; 229: 131-42.
31. Samra Y, Shaked Y, Maier MK. Nontyphoid salmonellosis in patients with total hip replacement: report of four cases and review of the literature. Rev Infect Dis 1986; 8: 978-83.
32. Widmer AF, Colombo VE, Gachter A et al. Salmonella infection in total hip replacement: tests to predict the outcome of antimicrobial therapy. Scand J Infect Dis 1990; 22: 611-8.
33. Sendi P, Banderet F, Graber P et al. Clinical comparison between exogenous and haematogenous periprosthetic joint infections caused by Staphylococcus aureus. Clin Microbiol Infect 2011; 17: 1098-100.
34. Sendi P, Christensson B, Uckay I et al. Group B streptococcus in prosthetic hip and knee joint-associated infections. J Hosp Infect 2011; 79: 64-9.
35. Hsieh PH, Lee MS, Hsu KY et al. Gram-negative prosthetic joint infections: risk factors and outcome of treatment. Clin Infect Dis 2009; 49: 1036-43.
36. Zimmerli W, Ochsner PE. Management of infection associated with prosthetic joints. Infection 2003; 31: 99-108.
37. Fernandez Guerrero ML, Gonzalez Lopez JJ, Goyenechea A et al. Endocarditis caused by Staphylococcus aureus: A reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome. Medicine (Baltimore) 2009; 88: 1-22.
38. Fowler VG Jr, Sanders LL, Kong LK et al. Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis 1999; 28: 106-14.
39. Elek SD, Conen PE. The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection. Br J Exp Pathol 1957; 38: 573-86.
40. Blomgren G, Lundquist H, Nord CE et al. Late anaerobic haematogenous infection of experimental total joint replacement. A study in the rabbit using Propionibacterium acnes. J Bone Joint Surg Br 1981; 63B: 614-8.
41. Blomgren G, Lindgren U. Late hematogenous infection in total joint replacement: studies of gentamicin and bone cement in the rabbit. Clin Orthop Relat Res 1981; 155: 244-8.
42. Zimmerli W, Zak O, Vosbeck K. Experimental hematogenous infection of subcutaneously implanted foreign bodies. Scand J Infect Dis 1985; 17: 303-10.
43. Berbari EF, Osmon DR, Carr A et al. Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis 2010; 50: 8-16.
44. Caspi I, Ezra E, Lin E et al. Salmonella osteomyelitis after internal fixation of fracture. Orthop Rev 1986; 15: 174-6.
45. Lalani T, Chu VH, Grussemeyer CA et al. Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infections. Scand J Infect Dis 2008; 40: 973-7.
46. Giulieri SG, Graber P, Ochsner PE et al. Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection 2004; 32: 222-8.
47. Worlock P, Slack R, Harvey L et al. The prevention of infection in open fractures: an experimental study of the effect of fracture stability. Injury 1994; 25: 31-8.
48. Rightmire E, Zurakowski D, Vrahas M. Acute infections after fracture repair: management with hardware in place. Clin Orthop Relat Res 2008; 466: 466-72.
49. Berkes M, Obremskey WT, Scannell B et al. Maintenance of hardware after early postoperative infection following fracture internal fixation. J Bone Joint Surg Am 2010; 92: 823-8.
50. Trampuz A, Zimmerli W. Diagnosis and treatment of infections associated with fracture-fixation devices. Injury 2006; 37(Suppl. 2): S59-66.
51. Westrich GH, Bornstein L, Brause BD et al. Historical perspective on two-stage reimplantation for infection after total hip arthroplasty at Hospital for Special Surgery, New York City. Am J Orthop (Belle Mead NJ) 2011; 40: E236-40.
52. De Man FH, Sendi P, Zimmerli W et al. Infectiological, functional, and radiographic outcome after revision for prosthetic hip infection according to a strict algorithm. Acta Orthop 2011; 82: 27-34.
53. Brandt CM, Sistrunk WW, Duffy MC et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 1997; 24: 914-9.
54. Marculescu CE, Berbari EF, Hanssen AD et al. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 2006; 42: 471-8.
55. Deirmengian C, Greenbaum J, Lotke PA et al. Limited success with open debridement and retention of components in the treatment of acute Staphylococcus aureus infections after total knee arthroplasty. J Arthroplasty 2003; 18(7 Suppl. 1): 22-6.
56. Lora-Tamayo J, Murillo O, Ariza J. Reply to Krause et al. Clin Infect Dis 2013; 56: 1843-4.
57. Krause R, Hoenigl M, Valentin T et al. Debridement antibiotic therapy and implant retention in staphylococcus aureus prosthetic joint infections. Clin Infect Dis 2013; 56: 1843.
58. Sendi P, Zimmerli W. Antimicrobial treatment concepts for orthopaedic device-related infection. Clin Microbiol Infect 2012; 18: 1176-84.
59. Anderl JN, Zahller J, Roe F et al. Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2003; 47: 1251-6.
60. Baldoni D, Haschke M, Rajacic Z et al. Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection. Antimicrob Agents Chemother 2009; 53: 1142-8.
61. Furustrand Tafin U, Majic I, Zalila Belkhodja C et al. Gentamicin improves the activities of daptomycin and vancomycin against Enterococcus faecalis in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother 2011; 55: 4821-7.
62. Furustrand Tafin U, Corvec S, Betrisey B et al. Role of rifampin against Propionibacterium acnes biofilm in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother 2012; 56: 1885-91.
63. John AK, Baldoni D, Haschke M et al. Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin. Antimicrob Agents Chemother 2009; 53: 2719-24.
64. Schwank S, Rajacic Z, Zimmerli W et al. Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics. Antimicrob Agents Chemother 1998; 42: 895-8.
65. Corvec S, Furustrand Tafin U, Betrisey B et al. Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrum-beta-lactamase-producing Escherichia coli in a foreign-body infection model. Antimicrob Agents Chemother 2013; 57: 1421-7.
66. Widmer AF, Wiestner A, Frei R et al. Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections. Antimicrob Agents Chemother 1991; 35: 741-6.
67. Widmer AF, Frei R, Rajacic Z et al. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis 1990; 162: 96-102.
68. Zimmerli W, Frei R, Widmer AF et al. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother 1994; 33: 959-67.
69. Trampuz A, Murphy CK, Rothstein DM et al. Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection. Antimicrob Agents Chemother 2007; 51: 2540-5.
70. Blaser J, Vergeres P, Widmer AF et al. In vivo verification of in vitro model of antibiotic treatment of device-related infection. Antimicrob Agents Chemother 1995; 39: 1134-9.
71. Mathur T, Bhateja P, Pandya M et al. In vitro activity of RBx 7644 (ranbezolid) on biofilm producing bacteria. Int J Antimicrob Agents 2004; 24: 369-73.
72. Widmer AF, Gaechter A, Ochsner PE et al. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis 1992; 14: 1251-3.
73. El Helou OC, Berbari EF, Lahr BD et al. Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention. Eur J Clin Microbiol Infect Dis 2011; 29: 961-7.
74. Peel TN, Buising KL, Dowsey MM et al. Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapy. Antimicrob Agents Chemother 2013; 57: 350-5.
75. Garrigos C, Murillo O, Lora-Tamayo J et al. Efficacy of daptomycin-cloxacillin combination in experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2012; 56: 3806-11.
76. Hudetz D, Ursic Hudetz S, Harris LG et al. Weak effect of metal type and ica genes on staphylococcal infection of titanium and stainless steel implants. Clin Microbiol Infect 2008; 14: 1135-45.
77. Herrmann M, Vaudaux PE, Pittet D et al. Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis 1988; 158: 693-701.
78. Lopes JD, dos Reis M, Brentani RR. Presence of laminin receptors in Staphylococcus aureus. Science 1985; 229: 275-7.
79. Rochford ET, Richards RG, Moriarty TF. Influence of material on the development of device-associated infections. Clin Microbiol Infect 2012; 18: 1162-7.
80. Provenza G, Provenzano M, Visai L et al. Functional analysis of a murine monoclonal antibody against the repetitive region of the fibronectin-binding adhesins fibronectin-binding protein A and fibronectin-binding protein B from Staphylococcus aureus. FEBS J 2010; 277: 4490-505.
81. Darouiche RO, Raad II, Heard SO et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 1999; 340: 1-8.
82. Simchi A, Tamjid E, Pishbin F et al. Recent progress in inorganic and composite coatings with bactericidal capability for orthopaedic applications. Nanomedicine 2011; 7: 22-39.
83. Kazemzadeh-Narbat M, Lai BF, Ding C et al. Multilayered coating on titanium for controlled release of antimicrobial peptides for the prevention of implant-associated infections. Biomaterials 2013; 34: 5969-77.
84. Gordon O, Vig Slenters T, Brunetto PS et al. Silver coordination polymers for prevention of implant infection: thiol interaction, impact on respiratory chain enzymes, and hydroxyl radical induction. Antimicrob Agents Chemother 2010; 54: 4208-18.
85. Anguita-Alonso P, Giacometti A, Cirioni O et al. RNAIII-inhibiting-peptide-loaded polymethylmethacrylate prevents in vivo Staphylococcus aureus biofilm formation. Antimicrob Agents Chemother 2007; 51: 2594-6.
86. Garrigos C, Murillo O, Lora-Tamayo J et al. RNAIII inhibiting peptide against foreign-body infection by methicillin-resistant Staphylococcus aureus. J Infect 2012; 65: 586-8.